Lupus Flare-Ups Strongly Linked to Specific Bacterial Growth in Gut

Researchers at NYU Grossman School of Medicine have found some of the strongest evidence yet linking lupus flare-ups to a specific imbalance in gut bacteria — a discovery that could point toward an entirely new class of treatments for the disease. The study, published in the Annals of Rheumatic Diseases, found that bacterial blooms of Ruminococcus gnavus in the gut occurred simultaneously with disease flare-ups in a subset of lupus patients tracked over four years.

In the study of 16 women with systemic lupus erythematosus, five experienced R. gnavus blooms that coincided with active flares. Four of those patients had lupus nephritis — the severe, kidney-targeting form of the disease — while the fifth had multi-joint inflammation. The research identified 34 genes already linked to the bacterium’s growth in people with inflammation, and found that immune antibodies reacted strongly to specific lipoglycan molecules on the bacterial wall — molecules found in lupus patients but not in healthy individuals.

The findings suggest a biological mechanism: R. gnavus blooms may weaken the gut wall, allowing bacterial material to leak into the bloodstream and trigger the runaway immune responses that define lupus. If confirmed at scale, this could open the door to treatments based on probiotics, dietary interventions, or targeted antibacterial agents — approaches that would be less toxic than the broad immunosuppressants currently used to manage the disease.